Concepedia

Helena Villanueva

HV

Statistics

Publications

15

Citations

984

H-Index

14

Active since

2001

Affiliations

Universidad de Navarra(Current)

Complejo Hospitalario de Navarra

Navarre Institute of Health Research

Universidad de Salamanca

Yale University

Helena Villanueva is an author at Universidad de Navarra specializing in immunology, oncology, and cancer immunotherapy.

Publications per year

2001–2022

15

Publications

15

Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma

Maurizio Bendandi, Sylvestre Marillonnet, Romy Kandzia et al. · Annals of Oncology · 2010 · 187 citations · Full text

, , +14

Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma

Susana Inogés, Mercedes Rodrı́guez-Calvillo, Natalia Zabalegui et al. · JNCI Journal of the National Cancer Institute · 2006 · 149 citations · Full text

, , +17

CD28 Aptamers as Powerful Immune Response Modulators

Fernando Pastor, Mario Martínez Soldevilla, Helena Villanueva et al. · Molecular Therapy — Nucleic Acids · 2013 · 125 citations · Full text

, , +17

2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia

Mario Martínez Soldevilla, Helena Villanueva, Maurizio Bendandi et al. · Biomaterials · 2015 · 84 citations

, , +13

MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells

Mario Martínez Soldevilla, Helena Villanueva, Noëlia Casares et al. · Oncotarget · 2016 · 66 citations · Full text

, , +17

1–5 of 15